Shanghai Pharmaceuticals. 

$7.34
4
-$0.26-3.42% Monday 20:00

Statistics

Day High
7.6
Day Low
7.6
52W High
8.32
52W Low
7.07
Volume
400
Avg. Volume
131
Mkt Cap
27.22B
P/E Ratio
6.38
Dividend Yield
4.5%
Dividend
0.33

Upcoming

Dividends

4.5%Dividend Yield
Feb 26
$0.08
Sep 25
$0.20
Nov 24
$0.06
Sep 24
$0.28
Sep 23
$0.42
10Y Growth
3.16%
5Y Growth
-1.55%
3Y Growth
-6.77%
1Y Growth
19.03%

Earnings

28AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.19
0.41
0.62
0.84
Expected EPS
0.5718686259
Actual EPS
N/A

Financials

2.02%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
39.49BRevenue
799.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHPMY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Shanghai Pharmaceuticals Holding Co., Ltd. operates as an investment holding enterprise deeply embedded in China's pharmaceutical and healthcare industries. The company oversees a full range of activities, from the research and development of new drugs to their manufacturing, nationwide distribution, and retail sales of a diverse array of pharmaceutical and health-related products. Its operations are strategically managed across four primary divisions: Production, Distribution, Retail, and Other services. The company's extensive product catalog includes chemical compounds, biochemicals, traditional Chinese remedies, general healthcare items, and medical devices. These offerings are designed to address a broad spectrum of medical conditions, encompassing oncology, cardiovascular and cerebrovascular issues, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory conditions. Notably, their portfolio boasts over 700 distinct pharmaceutical formulations. Beyond product development and manufacturing, Shanghai Pharmaceuticals is a significant player in comprehensive pharmaceutical supply chain management. This involves sophisticated distribution, warehousing, logistics, and various value-added services, all provided to a wide range of clients including drug manufacturers and healthcare providers such as hospitals, other wholesalers, and individual retail pharmacies. Moreover, the company maintains a substantial retail footprint, managing an extensive network of roughly 2,000 chain pharmacies spread across 24 provinces, alongside a thriving online drug commerce platform. Its diverse service offerings further extend to consulting, asset management, facilitating clinical trials, offering medical assistance, educating both medical professionals and patients, handling electronic prescriptions, and pioneering remote and cloud-based hospital solutions. Established in Shanghai in 1994, Shanghai Pharmaceuticals Holding Co., Ltd. functions as a subsidiary under Shanghai Pharmaceutical (Group) Co., Ltd.
Show more...
CEO
Mr. Qiuhua Yang
Employees
49608
Country
China
ISIN
US81943R1005

Listings

0 Comments

Share your thoughts

FAQ

What is Shanghai Pharmaceuticals. stock price today?
The current price of SHPMY is $7.34 USD — it has decreased by -3.42% in the past 24 hours. Watch Shanghai Pharmaceuticals. stock price performance more closely on the chart.
What is Shanghai Pharmaceuticals. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Shanghai Pharmaceuticals. stocks are traded under the ticker SHPMY.
Is Shanghai Pharmaceuticals. stock price growing?
SHPMY stock has risen by +0% compared to the previous week, the month change is a -3.42% fall, over the last year Shanghai Pharmaceuticals. has showed a -1.87% decrease.
What is Shanghai Pharmaceuticals. market cap?
Today Shanghai Pharmaceuticals. has the market capitalization of 27.22B
When is the next Shanghai Pharmaceuticals. earnings date?
Shanghai Pharmaceuticals. is going to release the next earnings report on August 28, 2026.
What were Shanghai Pharmaceuticals. earnings last quarter?
SHPMY earnings for the last quarter are 0.06 USD per share, whereas the estimation was 0.05 USD resulting in a +7.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Shanghai Pharmaceuticals. revenue for the last year?
Shanghai Pharmaceuticals. revenue for the last year amounts to 39.49B USD.
What is Shanghai Pharmaceuticals. net income for the last year?
SHPMY net income for the last year is 799.26M USD.
Does Shanghai Pharmaceuticals. pay dividends?
Yes, SHPMY dividends are paid semi-annual. The last dividend per share was 0.08 USD. As of today, Dividend Yield (FWD)% is 4.5%.
How many employees does Shanghai Pharmaceuticals. have?
As of July 21, 2026, the company has 49,608 employees.
In which sector is Shanghai Pharmaceuticals. located?
Shanghai Pharmaceuticals. operates in the Health & Wellness sector.
When did Shanghai Pharmaceuticals. complete a stock split?
Shanghai Pharmaceuticals. has not had any recent stock splits.
Where is Shanghai Pharmaceuticals. headquartered?
Shanghai Pharmaceuticals. is headquartered in Shanghai, China.